Jalal, Arif Hanafi Bin
Gunn, Harriet
Gunasekara, Buddhi
Gan, Hoong-Wei https://orcid.org/0000-0001-6198-0397
Article History
Received: 26 July 2024
Accepted: 20 November 2024
First Online: 13 December 2024
Declarations
:
: This study was registered as a service evaluation project by the Joint Research and Development Office for Great Ormond Street Hospital and UCL Great Ormond Street Institute of Child Health. No ethics approval was therefore required.
: Financial Interests: AHBJ had previously been employed by VineHealth a Medical Technology company contracted by Novartis to conduct research relating to Tafinlar (dabrafenib) and Mekinist (trametinib). AHBJ was not directly involved in this work.